KOPRAN
Back to Income Statement
|
KOPRAN Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹681 Cr | ₹630 Cr | ₹615 Cr | ₹551 Cr | ₹478 Cr |
What is the latest Revenue of KOPRAN ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹681 Cr |
| Mar2025 | ₹630 Cr |
| Mar2024 | ₹615 Cr |
| Mar2023 | ₹551 Cr |
| Mar2022 | ₹478 Cr |
How is Revenue of KOPRAN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹681 Cr | 8.23 | |
| Mar2025 | ₹630 Cr | 2.44 | |
| Mar2024 | ₹615 Cr | 11.54 | |
| Mar2023 | ₹551 Cr | 15.38 | |
| Mar2022 | ₹478 Cr | - | |
Compare Revenue of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹1,303.9 Cr | -7.1% | 16.3% | 57.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -7.1% |
16.3% |
57.1% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses